grupoorgafarma.com.br 的前十大競爭對手

neuca.pl

strona główna neuca.pl - wspieramy niezależnych farmaceutów

ocp.pt

Líder na distribuição farmacêutica desde 1946, a OCP Portugal garante acesso seguro e eficiente a medicamentos.

iwaki-kk.co.jp

イワキ株式会社は、アステナグループの一員として化粧品原料,機能性食品原料,健康食品原料,医療機器,バイオ関連製品を扱っています。

gnhindia.com

GNH India is a WHO-GSDP certified global pharmaceutical supplier based in Mumbai, India — specialising in named patient supply, orphan drug supply, clinical trial supply, and specialty medicine sourcing across 180+ countries. Founded 2003.

gaoipharma.com.tw

高一藥品股份有限公司以五十多年醫療供應業務實務經驗為基礎,從上游藥廠包括國外進口原廠及國內CGMP皆為長期策略合作夥伴,藥品種類高達5000種以上空間濕度及溫度嚴格控管,藥品完全把關保持最完善安全的狀態

koseipharma.com

光成薬品株式会社は、1952年創業の医薬品卸会社です。日本全国の病院、開業医、調剤薬局、薬店等に医薬品の販売・買取を行っています。

sterisindia.com

PROPASULES LA 40 is a premium pharmaceutical formulation containing Propranolol Hydrochloride Sustained Release Capsules IP 40 mg. Developed with advanced sustained-release technology, this formulation delivers the active ingredient gradually over an extended period, helping maintain consistent therapeutic levels while supporting the convenience of once-daily administration when prescribed by a healthcare professional. Manufactured in GMP-certified facilities using pharmaceutical-grade raw materials, PROPASULES LA 40 is produced under strict quality control measures to ensure purity, safety, and batch-to-batch consistency. It is intended for the treatment of medical conditions in which propranolol therapy is considered appropriate by a qualified physician. Composition Each Sustained Release Capsule Contains: Propranolol Hydrochloride IP – 40 mg Sustained Release Pellets Pharmaceutical Excipients – q.s. Capsule Shell – Approved pharmaceutical-grade ingredients Dosage Form: Sustained Release Capsules What is PROPASULES LA 40? PROPASULES LA 40 contains Propranolol Hydrochloride, a non-selective beta-adrenergic receptor blocker (beta-blocker) that helps manage a variety of cardiovascular and neurological conditions. The sustained-release formulation is specifically designed to release the medicine gradually throughout the day, providing prolonged therapeutic action and helping maintain stable plasma drug concentrations compared with conventional immediate-release formulations. Its controlled-release technology enhances dosing convenience and supports consistent treatment outcomes when used according to medical advice. Key Features Contains Propranolol Hydrochloride Sustained Release IP 40 mg Advanced sustained-release technology for prolonged drug delivery Supports once-daily dosing as prescribed Manufactured using premium pharmaceutical-grade ingredients Produced in GMP-compliant manufacturing facilities Stringent quality assurance for consistent product perfo

interpromet.biz

Analiza tržišta Istraživanje potražnje, konkurencije i potreba zdravstvenog sektora. Analiza konkurencije Procena tržišnog položaja i diferencijacija proizvoda. Kreiranje prodajne strategije Definisanje pristupa tržištu i prodajnih kanala. Definisanje ciljne grupe Identifikacija ključnih korisnika, uključujući lekare, farmaceute i medicinske ustanove. Marketing i media plan Osmišljavanje i sprovođenje promotivnih aktivnosti i oglašavanja.